Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, Follicular × durvalumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Sarcopenia 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

durvalumab 1 Sevoflurane 1 Rituximab 1 Radiotherapy 1 Propofol 1 Nivolumab 1 Massage 1 Ketamine 1 Fluorescence Polarization Immunoassay 1 Exercise 1 Echocardiography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610061 2024-04-12

RaDD

Austin Health

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡